BioSpace News Archive

RELIEF THERAPEUTICS Holding SA is pleased to announce the availability of the newest PKU GOLIKE BARs ® in Europe.

Embolx, Inc. announced the signing of a distribution agreement with Cardiva Italia SRL.

Evotec SE announced progress within the Company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline.

Coave Therapeutics announces that CEO Rodolphe Clerval will provide a company overview at the following conferences.

Telesis Bio Inc. announced Daniel Gibson, Ph.D., CTO and Co-founder of Telesis Bio will present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions” at the upcoming Festival of Biologics conference on March 21, 2023.

Seamless Therapeutics announced a $12.5 million seed financing round which will accelerate further development of its designer recombinases, a novel gene editing platform to transform the treatment of severe diseases.

Biogen Inc. announced that the Court of Justice of the European Union decided in favor of Biogen, the European Medicines Agency, and the European Commission in their appeal of a General Court decision annulling the EMA’s refusal to evaluate a generic version of TECFIDERA® because of TECFIDERA’s regulatory data and marketing protection.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD Vaginal Panel on the BD COR™ System.

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, provides a clinical development and operational update.

MediWound Ltd. is pleased to announce the appointment of Ms. Hani Luxenburg as its new Chief Financial Officer, effective May 14, 2023.